Ендоканабіноїдний енхансер (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ендоканабіноїдний енхансер" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

8nih.gov

4^th place

5^th place

6doi.org

2^nd place

4^th place

4worldcat.org

5^th place

9^th place

1books.google.com

3^rd place

11^th place

books.google.com

George I. Papakostas; Maurizio Fava (2010). Pharmacotherapy for Depression and Treatment-resistant Depression. World Scientific. с. 323–. ISBN 978-981-4287-59-3.

doi.org

Bambico, Francis Rodriguez; Gobbi, Gabriella (2008). The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion on Therapeutic Targets. 12 (11): 1347—1366. doi:10.1517/14728222.12.11.1347. ISSN 1472-8222. PMID 18851692.
Di Marzo, Vincenzo (2008). Targeting the endocannabinoid system: to enhance or reduce?. Nature Reviews Drug Discovery. 7 (5): 438—455. doi:10.1038/nrd2553. ISSN 1474-1776. PMID 18446159.
Saito, Viviane M.; Wotjak, Carsten T.; Moreira, Fabrício A. (2010). Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?. Rev Bras Psiquiatr. 32 (1): 57—514. doi:10.1590/S1516-44462010000500004. ISSN 1516-4446. PMID 20512266.
Micale, Vincenzo; Di Marzo, Vincenzo; Sulcova, Alexandra; Wotjak, Carsten T.; Drago, Filippo (2013). Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics. 138 (1): 18—37. doi:10.1016/j.pharmthera.2012.12.002. ISSN 0163-7258. PMID 23261685.
Anderson BJ (2008). Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 18 (10): 915—21. doi:10.1111/j.1460-9592.2008.02764.x. PMID 18811827.
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (2006). Paracetamol: new vistas of an old drug. CNS Drug Rev. 12 (3–4): 250—75. doi:10.1111/j.1527-3458.2006.00250.x. PMC 6506194. PMID 17227290.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bambico, Francis Rodriguez; Gobbi, Gabriella (2008). The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion on Therapeutic Targets. 12 (11): 1347—1366. doi:10.1517/14728222.12.11.1347. ISSN 1472-8222. PMID 18851692.
Di Marzo, Vincenzo (2008). Targeting the endocannabinoid system: to enhance or reduce?. Nature Reviews Drug Discovery. 7 (5): 438—455. doi:10.1038/nrd2553. ISSN 1474-1776. PMID 18446159.
Saito, Viviane M.; Wotjak, Carsten T.; Moreira, Fabrício A. (2010). Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?. Rev Bras Psiquiatr. 32 (1): 57—514. doi:10.1590/S1516-44462010000500004. ISSN 1516-4446. PMID 20512266.
Micale, Vincenzo; Di Marzo, Vincenzo; Sulcova, Alexandra; Wotjak, Carsten T.; Drago, Filippo (2013). Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics. 138 (1): 18—37. doi:10.1016/j.pharmthera.2012.12.002. ISSN 0163-7258. PMID 23261685.
Giuffrida A, Beltramo M, Piomelli D (2001). Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 298 (1): 7—14. PMID 11408519.
Anderson BJ (2008). Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth. 18 (10): 915—21. doi:10.1111/j.1460-9592.2008.02764.x. PMID 18811827.
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (2006). Paracetamol: new vistas of an old drug. CNS Drug Rev. 12 (3–4): 250—75. doi:10.1111/j.1527-3458.2006.00250.x. PMC 6506194. PMID 17227290.

ncbi.nlm.nih.gov

Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (2006). Paracetamol: new vistas of an old drug. CNS Drug Rev. 12 (3–4): 250—75. doi:10.1111/j.1527-3458.2006.00250.x. PMC 6506194. PMID 17227290.

worldcat.org

search.worldcat.org

Bambico, Francis Rodriguez; Gobbi, Gabriella (2008). The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion on Therapeutic Targets. 12 (11): 1347—1366. doi:10.1517/14728222.12.11.1347. ISSN 1472-8222. PMID 18851692.
Di Marzo, Vincenzo (2008). Targeting the endocannabinoid system: to enhance or reduce?. Nature Reviews Drug Discovery. 7 (5): 438—455. doi:10.1038/nrd2553. ISSN 1474-1776. PMID 18446159.
Saito, Viviane M.; Wotjak, Carsten T.; Moreira, Fabrício A. (2010). Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?. Rev Bras Psiquiatr. 32 (1): 57—514. doi:10.1590/S1516-44462010000500004. ISSN 1516-4446. PMID 20512266.
Micale, Vincenzo; Di Marzo, Vincenzo; Sulcova, Alexandra; Wotjak, Carsten T.; Drago, Filippo (2013). Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics. 138 (1): 18—37. doi:10.1016/j.pharmthera.2012.12.002. ISSN 0163-7258. PMID 23261685.